{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:54:14Z","timestamp":1791582854436,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.dld.2026.09.013","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:15:07Z","timestamp":1791580507000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adherence to advanced therapies in inflammatory bowel diseases: Real-world rates and predictors of non-adherence"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2818-916X","authenticated-orcid":false,"given":"De Cristofaro","family":"Elena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorzi","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuccagna","family":"Elisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3489-3495","authenticated-orcid":false,"given":"Colella","family":"Alice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doni","family":"Laura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucarelli","family":"Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-3235","authenticated-orcid":false,"given":"Marafini","family":"Irene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monteleone","family":"Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2177-0421","authenticated-orcid":false,"given":"Calabrese","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2026.09.013_bib0001","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","article-title":"Crohn\u2019s disease","volume":"403","author":"Dolinger","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2026.09.013_bib0002","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/apt.14063","article-title":"Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis","volume":"45","author":"Roda","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2026.09.013_bib0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004836-198208000-00008","article-title":"Compliance to therapy in patients on a maintenance dose of sulfasalazine","volume":"4","author":"van Hees","year":"1982","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2026.09.013_bib0004","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1572-0241.2001.04683.x","article-title":"Predictors of non-compliance with mesalamine in quiesecent ulcerative colitis","volume":"96","author":"Kane","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.09.013_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ajg.2009.685","article-title":"Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review","volume":"105","author":"Jackson","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2026.09.013_bib0006","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5217\/ir.2017.15.4.434","article-title":"Medication adherence in in-flammatory bowel disease","volume":"15","author":"Chan","year":"2017","journal-title":"Intest Res"},{"key":"10.1016\/j.dld.2026.09.013_bib0007","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2147\/PPA.S424024","article-title":"What do we know about medication adherence interventions in inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis? A scoping review of randomised controlled trials","volume":"17","author":"King","year":"2023","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.dld.2026.09.013_bib0008","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ibd\/izz253","article-title":"Risk factors for medication nonadherence to self-injectable biologic therapy in adult patients with inflammatory bowel disease","volume":"26","author":"Shah","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"8167","key":"10.1016\/j.dld.2026.09.013_bib0009","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","article-title":"A simple index of Crohn's-disease activity","volume":"315","author":"Harvey","year":"1980","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.dld.2026.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cgh.2009.06.024","article-title":"A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis","volume":"7","author":"Turner","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.dld.2026.09.013_bib0011","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.dld.2025.04.032","article-title":"Therapeutic adherence in inflammatory bowel disease: user guide from a multidisciplinary modified Delphi consensus","volume":"57","author":"Dal Buono","year":"2025","journal-title":"Dig Liv Dis"},{"issue":"1","key":"10.1016\/j.dld.2026.09.013_bib0012","first-page":"21","article-title":"Medication non-adherence in inflammatory bowel disease: a systematic review identifying risk factors and opportunities for intervention","volume":"13","author":"King","year":"2025","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.dld.2026.09.013_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102850","article-title":"Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics","volume":"77","author":"Feig","year":"2024","journal-title":"EclinicalMedicine"},{"key":"10.1016\/j.dld.2026.09.013_bib0014","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/MIB.0b013e31829ed8a6","article-title":"Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease","volume":"19","author":"Selinger","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.09.013_bib0015","first-page":"269","article-title":"Adherence to medical treatment in inflammatory bowel disease patients","volume":"60","author":"Zelante","year":"2014","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"7","key":"10.1016\/j.dld.2026.09.013_bib0016","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-2036.2006.03092.x","article-title":"Adherence rates with infliximab therapy in Crohn\u2019s disease","volume":"24","author":"Kane","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2026.09.013_bib0017","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jgh3.12160","article-title":"Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease","volume":"3","author":"Tomar","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.dld.2026.09.013_bib0018","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MPG.0b013e3182475e71","article-title":"Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease","volume":"54","author":"Kamperidis","year":"2012","journal-title":"J Paediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2026.09.013_bib0019","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/MEG.0000000000001436","article-title":"Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease","volume":"31","author":"Bruna-Barranco","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2026.09.013_bib0020","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/ibd\/izaa056","article-title":"Utility of the MARS-5 in assessing medication adherence in IBD","volume":"27","author":"Stone","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2026.09.013_bib0021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-230X-13-23","article-title":"Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database","volume":"13","author":"Lachaine","year":"2013","journal-title":"BMC Gastroenterol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826009667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826009667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:15:10Z","timestamp":1791580510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826009667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":21,"alternative-id":["S1590865826009667"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.09.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to advanced therapies in inflammatory bowel diseases: Real-world rates and predictors of non-adherence","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}